These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34825635)

  • 1. Erythrocyte-cancer Hybrid Membrane-camouflaged Mesoporous Silica Nanoparticles Loaded with Gboxin for Glioma-targeting Therapy.
    Jiao X; Yu X; Gong C; Zhu H; Zhang B; Wang R; Yuan Y
    Curr Pharm Biotechnol; 2022; 23(6):835-846. PubMed ID: 34825635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment.
    Zou Y; Sun Y; Wang Y; Zhang D; Yang H; Wang X; Zheng M; Shi B
    Nat Commun; 2023 Jul; 14(1):4557. PubMed ID: 37507371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes.
    Su J; Sun H; Meng Q; Zhang P; Yin Q; Li Y
    Theranostics; 2017; 7(3):523-537. PubMed ID: 28255347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
    Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
    Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
    Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
    ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy.
    Wang Y; Zhao K; Xie L; Li K; Zhang W; Xi Z; Wang X; Xia M; Xu L
    Colloids Surf B Biointerfaces; 2022 Apr; 212():112357. PubMed ID: 35101825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
    Wei Y; Gao L; Wang L; Shi L; Wei E; Zhou B; Zhou L; Ge B
    Drug Deliv; 2017 Nov; 24(1):681-691. PubMed ID: 28414557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
    Mo J; He L; Ma B; Chen T
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy.
    Rezaei Harandi Z; Heidari R; Reiisi S
    IEEE Trans Nanobioscience; 2023 Oct; 22(4):872-880. PubMed ID: 37022888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
    Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
    Zhang K; Zhou D; Wang Z; Zhang Y; He P
    Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
    Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ
    Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
    Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
    Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Delivery of Metformin Against Lung Cancer Cells Via Hyaluronan-Modified Mesoporous Silica Nanoparticles.
    Zhang F; Liu W; Long Y; Peng H
    Appl Biochem Biotechnol; 2023 Jul; 195(7):4067-4083. PubMed ID: 36652095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical Characterization and Safety Evaluation of Folic Acid-conjugated Mesoporous Silica Nanoparticles Loaded with Rhodojaponin III.
    Yang Q; Zhao C; Yang J; Zhao J; Feng Y; Liu M; Zhang J
    Curr Drug Deliv; 2023; 20(10):1559-1568. PubMed ID: 36366851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.